Drugs / Peginterferon Alpha
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01725529 Background | Nov 2012 → Aug 2014 | chronic hepatitis C virus infection | Janssen R&D Ireland | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01146626 Comparator | Aug 2011 → Feb 2012 | chronic hepatitis C virus infection | Ziv Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peginterferon Alpha | “Does Vitamin D Supplement Improve SVR in Chronic Hepatitis C (Genotype 2,3) in naïve Patients Treated With Peginterferon Alpha and Ribavirin” NCT01146626 ↗ |
| Route | Subcutaneous | “administered as weekly subcutaneous (s.c.) (under the skin) injections” NCT01725529 ↗ |